Tian F, Huang S, Xu W, Chen L, Su J, Ni H, et al
Key Pharmacokinetic Parameters The table below describes the key pharmacokinetic parameters for DPP-4 inhibitors: Cautions and contraindications Cautions and contraindications for the use of DPP-4 inhibitors are listed below: Adverse effects Other adverse effects include: Increased risk of infection with saxagliptin, alogliptin and vildagliptin Hypersensitivity reactions (including anaphylaxis, angioedema, stevens-johnson syndrome) Sitagliptin: interstitial lung disease, impaired renal function, thrombocytopenia, and acute renal failure
Diabetes (2005) 54:48291
The insulin receptor-deficient mice had been proved to show reduced bone resorption by osteoclasts, but the bone mass of these mice is still decreased, indicating that the inhibition of bone formation is stronger than that of bone resorption [19]
[15] [16] Routine thyroid function testing is not a standard class recommendation in UK or EU prescribing information for GLP-1 receptor agonists
Singh S, Saha P, Kumari S, Rai N, Pandey-Rai S (2025a) Unlocking the industrial potential of Withania somnifera (L.) Dunal: a varietal comparison of morphology, microstructure, and metabolomic profiles
